期刊文献+

丹芪合剂下调糖尿病肾病大鼠肾组织Akt1的表达 被引量:16

Danqi Mixture Down-regulates Akt1 Expression of Kidney Tissue in Diabetic Rats
原文传递
导出
摘要 目的:观察丹芪合剂对糖尿病大鼠肾组织蛋白激酶B(PKB/Akt1)表达的影响,探讨其保护肾脏的机制。方法:SD大鼠随机分为正常对照组、糖尿病模型组、糖尿病丹芪合剂组(2 g.kg-1)和依那普利组(10 mg.kg-1)。单次尾静脉注射链脲佐菌素复制糖尿病模型。生化方法检测血糖、尿蛋白和血肌酐。免疫组化检测肾组织Akt1、E-钙黏素(E-cadherin)、纤维连接蛋白(FN)蛋白表达;Western blot检测α-平滑肌肌动蛋白(α-SMA)蛋白水平;RT-PCR检测Akt1 mRNA水平。结果:丹芪合剂明显降低DM大鼠肾组织Akt1蛋白和mRNA表达(P<0.01);同时上调E-cadherin蛋白表达并下调α-SMA表达,使FN沉积减少(P<0.01);降低DM大鼠血肌酐和尿蛋白水平(P<0.05)。丹芪合剂组与依那普利组之间无统计学差异。结论:丹芪合剂可能通过抑制Akt信号分子,进而抑制上皮细胞-间充质细胞转化,减少FN沉积,对糖尿病大鼠肾脏起保护作用。 Objective: This research was aimed at observing the effect of the Danqi Mixture on the expression of Aktl in kidney tissue of diabetic rats and exploring it's mechanism of renal protection. Method: Healthy male Sprague-Dawley rats were divided into normal group (A), diabetic model group (B), diabetic group treated with Danqi (C) and Enalapril group (D) randomly. Diabetic rat model was induced using injection of 50 mg .kg-1 streptozotocin (STZ). Rats of each group were killed at the 12th week. Biochemistry assay was employed to assess the urine protein and serum creatinine. The protein expressions of Aktl, E-cadherin and fibronection (FN) in renal tissue were measured using immunohistochemistry, meanwhile a-smooth actin (a- SMA) protein expression level was detected by Western blot. The mRNA level of Aktl in renal cortex was examined by Reverse Transcriptose Polymerase Chain Reaction (RT-PCR). Result: Danqi mixture and enalapril down-regulated mRNA and protein expression of Aktl, and decreased protein expressions of a-SMA and FN (P 〈 0.01 ) , along with significantly increased level of E-cadherin protein in renal tissue diabetic rats ( P 〈 0.01 ). Comparing to the normal group, the levels of proteinuria, serum creatinine in Danqi Mixture group were remarkably decreased as well (P 〈0. 05 ). Conclusion: Danqi Mixture could inhibit epithelial-mesenchymal transition (EMT) and improve the injury of diabetic kidney, which might associate with the down-regulation of Aktl mRNA and protein expression.
机构地区 贵阳医学院
出处 《中国实验方剂学杂志》 CAS 北大核心 2013年第7期259-262,共4页 Chinese Journal of Experimental Traditional Medical Formulae
基金 贵州省科技厅攻关项目(2008-3042)
关键词 糖尿病肾病 AKT1 上皮细胞-间充质细胞转化 丹芪合剂 依那普利 diabetic nephropathy Aktl epithelial mesenchymal transition Danqi Mixture Enalapril
  • 相关文献

参考文献12

  • 1肖瑛,石明隽,桂华珍,郭兵,张国忠.丹芪合剂对DM大鼠肾小管BMP-7及其受体表达的影响[J].时珍国医国药,2009,20(10):2495-2497. 被引量:11
  • 2李晓颖,郭兵,刘瑞霞,肖瑛,石明隽,王圆圆,皮明婧,张国忠.丹芪合剂和依那普利对糖尿病大鼠肾小管HGF和SnoN表达的影响[J].时珍国医国药,2010,21(9):2184-2186. 被引量:5
  • 3徐叔云,卞如濂,陈修.药理实验方法学[M].3版.北京:人民卫生出版社,2005:1042-1043,1053.
  • 4Vasudevan K M and Garraway L A. Akt signaling in physiology and disease [ J ]. Curr Top Microbiol Immunol, 2010, 347(1) :105.
  • 5Heljic M, Brazil D P. Protein kinase B/Akt regulation in diabetic kidney disease [ J ]. Front Biosci (Schol Ed), 2011, 1(3):98.
  • 6Jayesh J Kattla, Rosemarie M Carew, Mediha Heljic, et al. Protein kinase B/Akt activity is involved in renal TGF-β1 -driven epithelial-mesenchymal transition in vitro and in vivo [ J ]. Am J Physiol Renal Physiol, 2008, 295 ( 1 ) :215.
  • 7Y H Liu. New insights into epithelial-mesenchymal transition in kidney fibrosis [ J ]. J Am Soe Nephrol, 2010, 21(2) :212.
  • 8Hills C E, Squires P E. The role of TGF-β and epithelial-to mesenchymal transition in diabetic nephropathy[ J]. Cytokine Growth Factor Rev, 2011,22(3):131.
  • 9Lee Y J, Han H J. Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snaill, and β-catenin in renal proximal tubule cells[J]. Am J Physiol Renal Physiol, 2010, 298(5): F1263.
  • 10Hao J, Liu S, Zhao S, et al. PI3K/Akt pathway mediates high glucose-induced lipogenesis and extracellular matrix accumulation in HKC eells through regulation of SREBP-1 and TGF-β1 [J]. Histoehem Cell Biol, 2011, 135(2): 173.

二级参考文献17

共引文献116

同被引文献230

引证文献16

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部